Cargando…
NPCDR: natural product-based drug combination and its disease-specific molecular regulation
Natural product (NP) has a long history in promoting modern drug discovery, which has derived or inspired a large number of currently prescribed drugs. Recently, the NPs have emerged as the ideal candidates to combine with other therapeutic strategies to deal with the persistent challenge of convent...
Autores principales: | Sun, Xueni, Zhang, Yintao, Zhou, Ying, Lian, Xichen, Yan, Lili, Pan, Ting, Jin, Ting, Xie, Han, Liang, Zimao, Qiu, Wenqi, Wang, Jianxin, Li, Zhaorong, Zhu, Feng, Sui, Xinbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728151/ https://www.ncbi.nlm.nih.gov/pubmed/34664659 http://dx.doi.org/10.1093/nar/gkab913 |
Ejemplares similares
-
SYNBIP: synthetic binding proteins for research, diagnosis and therapy
por: Wang, Xiaona, et al.
Publicado: (2021) -
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
por: Zhou, Ying, et al.
Publicado: (2021) -
DRESIS: the first comprehensive landscape of drug resistance information
por: Sun, Xiuna, et al.
Publicado: (2022) -
M6AREG: m(6)A-centered regulation of disease development and drug response
por: Liu, Shuiping, et al.
Publicado: (2022) -
SuperNatural 3.0—a database of natural products and natural product-based derivatives
por: Gallo, Kathleen, et al.
Publicado: (2022)